OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F4033, issued on April 1, 2026, for the supply of OMEPRAZOLE EXTENDED, identified by NSN 6505013142716. This award is issued under the parent contract SPE2DX25D9900 and is part of a federal procurement initiative managed by the Department of Defense. The total contract value is specified in the award documentation, though the exact amount is not disclosed here. The procurement is unfettered by any specific small business set-aside designation and falls under the federal agency category with no NAICS code listed. The place of performance and office address details are not provided, but the contract is administered by the Defense Logistics Agency and accessible via the DIBBS portal. Delivery of the pharmaceutical product is expected to support military medical requirements under the terms of this contractual obligation.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
